167 results
DEFA14A
ATRA
Atara Biotherapeutics Inc
26 Apr 24
Additional proxy soliciting materials
4:20pm
as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. For 4. To approve the Company’s 2024 Equity
424B5
s66m w9q0zi3ukbm0
9 Jan 24
Prospectus supplement for primary offering
4:28pm
8-K
EX-5.1
lu9zr3f ftrcrin7d5
9 Jan 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
opia ncjl7k4
9 Jan 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-99.1
7lj7i8lkym9
8 Jan 24
Cost Associated with Exit or Disposal Activities
8:11am
S-8
uyaq3 aw0pvd8v
3 Jan 24
Registration of securities for employees
4:09pm
S-8
EX-5.1
u329ad6dnc0zh
3 Jan 24
Registration of securities for employees
4:09pm
S-8
EX-23.2
8usn78 6y7p5sgoffsx6
3 Jan 24
Registration of securities for employees
4:09pm
424B3
om29nw0
17 Nov 23
Prospectus supplement
4:31pm
8-K
EX-1.1
4loyx x15n99
1 Nov 23
Other Events
4:05pm